Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Klay Biotech is a private UK health technology company developing an AI-driven 3D software platform for craniofacial surgery. Its platform is designed to help surgeons and patients collaboratively plan cranial and facial procedures by predicting soft-tissue outcomes from bone-shape changes and supporting custom implant design. The company combines photogrammetry, CT-based modeling, finite element methods, and machine-learning algorithms to improve precision, workflow efficiency, and personalization in reconstructive and aesthetic surgery. Klay appears to operate as a surgical planning and implant-design platform business rather than as a traditional therapeutic drug developer, with a subscription-based software model and additional fees for implant design services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Klay Biotech.